cerrar
Tagged with Pharmaceuticals

Interview: Reynold W. (Pete) Mooney – Managing Director,…
Latin America provides a number of opportunities to healthcare and life sciences companies. The Managing Director for the Global Life Sciences and…

Interview: Rikus Wolbers and John Schalken – Novio Tech…
Rikus Wolbers, Director at Novio Tech Campus, a key international incubator for R&D and manufacturing companies who are active at the interface of…

Interview: Hatem Safei – Managing Director, Bayer Egypt
Bayer broke into the top ten multinationals in Egypt this year, after achieving a remarkable 110 percent growth over the last two years. General…

Interview: Ronald Brus – CEO, myTomorrows, The…
Harnessing the power of big data and the Internet, myTomorrows is working to help patients in need to access treatments that would otherwise not be…

Interview: Onno van de Stolpe – CEO, Galapagos, The…
After a successful IPO on Nasdaq in May 2015, Galapagos is ready to continue developing its robust portfolio of clinical-stage breakthrough therapies…

Interview: Leo Le Duc – Director, Amsterdam Science Park,…
Leo Le Duc, Director of Amsterdam Science Park, explains the potential of Amsterdam Science Park as a world-class eco-system for start-ups, mature…

Interview: Andrea van Elsas – CSO & Hans van Eenennaam…
The CSO and COO of BioNovion talk about the company's recent acquisition by US-based biotech Aduro. BioNovion is a Dutch biopharma specialized in…

Interview: Stefan Braam – CEO, Pluriomics, The Netherlands
Stem cell technology can play a key role in improving the drug discovery process. The CEO of Pluriomics, a biotech company focused on development of…

Interview: Patrick Bourdet – President and CEO, AREVA Med,…
The president and CEO of AREVA Med, the medical subsidiary of AREVA Group, the biggest nuclear company in the world, discusses the circumstances that…

Interview: Dominique Giorgi – President, CEPS (Comité…
The President of CEPS, the French pricing agency, reveals the issues around the launch of the hepatitis C drug Sovaldi in 2014 and of CEPS´ role…

Interview: AbdelAziz Shaheen – Country Manager, Pfizer…
 Country manager AbdelAziz Shaheen discusses Pfizer’s current and recent investments in Egypt, which include significant contributions to the…

Interview: Ashraf El Khouly – Executive Director, Egyptian…
“Egypt will become the largest market for pharmaceuticals within the region in the next three years”; Ahsraf Elkhouly, Executive Director the…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here